Compugen (CGEN) Invested Capital (2009 - 2025)

Compugen recorded quarterly Invested Capital of $102.7 million in Q4 2025, up 87.08% quarter-over-quarter from $54.9 million in Q4 2024, and up 87.08% year-over-year from $54.9 million in Q4 2024.

Compugen's Invested Capital history runs 11 years deep, the most recent figure standing at $102.7 million for Q4 2025.

  • In Q4 2025, Invested Capital rose 87.08% year-over-year to $102.7 million; the TTM figure through Dec 2025 stood at $102.7 million (up 87.08% YoY), while the FY2025 annual figure was $102.7 million, up 87.08% from the prior year.
  • Invested Capital came in at $102.7 million for Q4 2025 at Compugen, up from $54.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $106.7 million in Q4 2021 to a low of $54.9 million in Q4 2024.
  • A 5-year average of $81.5 million and a median of $77.7 million in 2022 frame the typical range for Invested Capital.
  • Across the five-year window, Invested Capital slipped 27.19% in 2022 and soared 87.08% in 2025, its largest moves.
  • Compugen's Invested Capital stood at $106.7 million in 2021, then retreated by 27.19% to $77.7 million in 2022, then declined by 15.6% to $65.6 million in 2023, then dropped by 16.24% to $54.9 million in 2024, then surged by 87.08% to $102.7 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods registered $102.7 million, $54.9 million, and $65.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 102.73 Mn
Sep 30, 2025 43.83 Mn
Jun 30, 2025 50.26 Mn
Mar 31, 2025 57.11 Mn
Dec 31, 2024 54.91 Mn
Sep 30, 2024 60.49 Mn
Jun 30, 2024 58.34 Mn
Mar 31, 2024 59.68 Mn
Dec 31, 2023 65.56 Mn
Sep 30, 2023 53.23 Mn
Jun 30, 2023 62.00 Mn
Mar 31, 2023 69.21 Mn
Dec 31, 2022 77.68 Mn
Sep 30, 2022 79.82 Mn
Jun 30, 2022 90.38 Mn
Mar 31, 2022 98.15 Mn
Dec 31, 2021 106.69 Mn
Sep 30, 2021 98.82 Mn
Jun 30, 2021 103.42 Mn
Mar 31, 2021 110.86 Mn
Dec 31, 2020 119.78 Mn
Sep 30, 2020 127.24 Mn
Jun 30, 2020 129.47 Mn
Mar 31, 2020 114.11 Mn
Dec 31, 2019 38.32 Mn
Sep 30, 2019 41.86 Mn
Jun 30, 2019 31.80 Mn
Mar 31, 2019 33.28 Mn
Dec 31, 2018 37.24 Mn
Sep 30, 2018 38.17 Mn
Jun 30, 2018 40.55 Mn
Mar 31, 2018 30.41 Mn
Dec 31, 2017 29.30 Mn
Sep 30, 2017 38.00 Mn
Jun 30, 2017 47.22 Mn
Mar 31, 2017 55.77 Mn
Dec 31, 2016 63.52 Mn
Sep 30, 2016 70.35 Mn
Jun 30, 2016 77.13 Mn
Mar 31, 2016 82.89 Mn
Dec 31, 2015 89.90 Mn
Sep 30, 2015 89.41 Mn
Jun 30, 2015 95.41 Mn
Mar 31, 2015 100.96 Mn
Dec 31, 2014 106.12 Mn
Sep 30, 2014 106.32 Mn
Jun 30, 2014 98.13 Mn
Mar 31, 2014 99.95 Mn
Dec 31, 2013 31.89 Mn
Sep 30, 2013 27.03 Mn
Jun 30, 2013 20.71 Mn
Mar 31, 2013 21.76 Mn
Dec 31, 2012 17.67 Mn
Sep 30, 2012 18.69 Mn
Jun 30, 2012 21.89 Mn
Mar 31, 2012 21.25 Mn
Dec 31, 2011 19.58 Mn
Sep 30, 2011 22.20 Mn
Jun 30, 2011 25.82 Mn
Mar 31, 2011 26.92 Mn
Dec 31, 2010 28.29 Mn
Sep 30, 2010 26.86 Mn
Jun 30, 2010 26.34 Mn
Mar 31, 2010 28.63 Mn
Dec 31, 2009 27.40 Mn
Sep 30, 2009 9.39 Mn
Jun 30, 2009 10.95 Mn
Mar 31, 2009 8.91 Mn